AAAAAA

   
Results: 1-8 |
Results: 8
T-CELL RECEPTOR PEPTIDE VACCINATION IN RHEUMATOID-ARTHRITIS - A PLACEBO-CONTROLLED TRIAL USING A COMBINATION OF V(BETA)3, V(BETA)14, AND V(BETA)17 PEPTIDES
Authors: MORELAND LW MORGAN EE ADAMSON TC FRONEK Z CALABRESE LH CASH JM MARKENSON JA MATSUMOTO AK BATHON J MATTESON EL URAMOTO KM WEYAND CM KOOPMAN WJ HECK LW STRAND V DIVELEY JP CARLO DJ NARDO CJ RICHIERI SP BROSTOFF SW
Citation: Lw. Moreland et al., T-CELL RECEPTOR PEPTIDE VACCINATION IN RHEUMATOID-ARTHRITIS - A PLACEBO-CONTROLLED TRIAL USING A COMBINATION OF V(BETA)3, V(BETA)14, AND V(BETA)17 PEPTIDES, Arthritis and rheumatism, 41(11), 1998, pp. 1919-1929
ASSOCIATION OR DPB1 GENES WITH SYSTEMIC LUPUS-ERYTHEMATOSUS
Authors: FRONEK Z CHEUNG MM MCDEVITT HO
Citation: Z. Fronek et al., ASSOCIATION OR DPB1 GENES WITH SYSTEMIC LUPUS-ERYTHEMATOSUS, Journal of rheumatology, 24(1), 1997, pp. 232-234
V-BETA-17 T-CELL RECEPTOR PEPTIDE VACCINATION IN RHEUMATOID-ARTHRITIS- RESULTS OF PHASE-I DOSE-ESCALATION STUDY
Authors: MORELAND LW HECK LW KOOPMAN WJ SAWAY PA ADAMSON TC FRONEK Z OCONNOR RD MORGAN EE DIVELEY JP RICHIERI SP CARLO DJ BROSTOFF SW
Citation: Lw. Moreland et al., V-BETA-17 T-CELL RECEPTOR PEPTIDE VACCINATION IN RHEUMATOID-ARTHRITIS- RESULTS OF PHASE-I DOSE-ESCALATION STUDY, Journal of rheumatology, 23(8), 1996, pp. 1353-1362
V-BETA-17 T-CELL RECEPTOR PEPTIDE VACCINE - RESULTS OF A PHASE-I DOSE-FINDING STUDY IN PATIENTS WITH RHEUMATOID-ARTHRITIS
Authors: MORELAND LW HECK LW KOOPMAN WJ SAWAY PA ADAMSON TC FRONEK Z OCONNOR RD MORGAN EE BROSTOFF SW
Citation: Lw. Moreland et al., V-BETA-17 T-CELL RECEPTOR PEPTIDE VACCINE - RESULTS OF A PHASE-I DOSE-FINDING STUDY IN PATIENTS WITH RHEUMATOID-ARTHRITIS, Clinical research, 42(2), 1994, pp. 10000312-10000312
V-BETA-17 T-CELL RECEPTOR PEPTIDE VACCINE - RESULTS OF A PHASE-I DOSE-FINDING STUDY IN PATIENTS WITH RHEUMATOID-ARTHRITIS
Authors: MORELAND LW HECK LW KOOPMAN WJ SAWAY PA ADAMSON TC FRONEK Z OCONNOR RD MORGAN EE
Citation: Lw. Moreland et al., V-BETA-17 T-CELL RECEPTOR PEPTIDE VACCINE - RESULTS OF A PHASE-I DOSE-FINDING STUDY IN PATIENTS WITH RHEUMATOID-ARTHRITIS, Arthritis and rheumatism, 37(6), 1994, pp. 180000028-180000028
MULTIPLE DQA1 DQB1 ALLELES LINKED TO HLA-DRB1 GENES ENCODING HLA-DR3,DR5, OR DRW6 - GENE DOSAGE EFFECT IN PRIMARY SJOGRENS-SYNDROME (PSS) AND PRESUMED LUPUS VARIANTS (PLVS)/
Authors: ALEXANDER EL PLITT JR ANSARI A EHRLICH H BUGAWAN D FRONEK Z
Citation: El. Alexander et al., MULTIPLE DQA1 DQB1 ALLELES LINKED TO HLA-DRB1 GENES ENCODING HLA-DR3,DR5, OR DRW6 - GENE DOSAGE EFFECT IN PRIMARY SJOGRENS-SYNDROME (PSS) AND PRESUMED LUPUS VARIANTS (PLVS)/, The Journal of immunology, 150(8), 1993, pp. 237-237
HLA-CLASS-II ASSOCIATED TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA) SYNTHESIS IN CENTRAL-NERVOUS-SYSTEM DISEASE IN SJOGRENS-SYNDROME (CNS-SS)
Authors: JACOB CO PLITT JR FRONEK Z KOO M ALEXANDER EL
Citation: Co. Jacob et al., HLA-CLASS-II ASSOCIATED TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA) SYNTHESIS IN CENTRAL-NERVOUS-SYSTEM DISEASE IN SJOGRENS-SYNDROME (CNS-SS), The Journal of immunology, 150(8), 1993, pp. 238-238
GENE DOSAGE EFFECT IN PRIMARY SJOGRENS-SYNDROME (PSS) AND PRESUMED LUPUS VARIANTS (PLVS) - MULTIPLE DQA1 DQB1 ALLELES LINKED TO HLA-DRE1 GENES ENCODING-9 EYSTS-13 CONTAINING HLA-DR3, DR5, OR DRW6 (DQA1/DQB1 EYSTS)/
Authors: ALEXANDER EL PLITT JR ANSARI A EHRLICH H BUGAWAN D FRONEK Z
Citation: El. Alexander et al., GENE DOSAGE EFFECT IN PRIMARY SJOGRENS-SYNDROME (PSS) AND PRESUMED LUPUS VARIANTS (PLVS) - MULTIPLE DQA1 DQB1 ALLELES LINKED TO HLA-DRE1 GENES ENCODING-9 EYSTS-13 CONTAINING HLA-DR3, DR5, OR DRW6 (DQA1/DQB1 EYSTS)/, Arthritis and rheumatism, 36(5), 1993, pp. 24-24
Risultati: 1-8 |